Pathways and Receptors – Opioid Peptides
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
κ-opioid receptor - Wikipedia
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
IJMS | Free Full-Text | Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age | Neuropsychopharmacology
Neurophysiological process - Kappa-type opioid receptor in transmission of nerve impulses Pathway Map - PrimePCR | Life Science | Bio-Rad
κ-opioid receptor - Wikipedia
opioid receptor (English) - Medical terminology for medical students - - YouTube
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Opioid Receptor | kappa, mu Opioid Receptor
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
